2
Views
0
CrossRef citations to date
0
Altmetric
CLINICAL ARTICLES

Choosing a drug regimen for obstructive pulmonary disease

1. Agents to achieve bronchodilatation

, MD
Pages 36-48 | Published online: 07 Jul 2016

References

  • Schultz G, Hard man JG, Sutherland EW: Cyclic nucleotides and smooth muscle function. In Austen KF, Lichtenstein LM (Editors): Asthma. New York, Academic Press, Inc, 1973, pp 123–137
  • Austen KF, Orange RP: Bronchial asthma: The possible role of the chemical mediators of immediate hypersensitivity in the pathogenesis of subacute chronic disease. Am Rev Respir Dis 112: 423–436, 1975
  • Ahlquist RP: Study of adrenotropic receptors. Am J Physiol 135: 586–600, 1948
  • Lands AM, Arnold A, McAuliff JP, et al: Differentiation of receptor systems activated by sympathomimetic amines. Nature 214: 597–598, 1967
  • Jack D: Selectively acting beta-adrenoreceptor stimulants in asthma. In Austen KF, Lichtenstein LM (Editors),1 pp 251–265
  • Leifer KN, Wittig HJ: The beta-2 sympathomimetic aerosols in the treatment of asthma. Ann Allergy 35: 69–80, 1975
  • As AA: Beta-adrenergic stimulant bronchodilators. In Stein M (Editor): New Directions in Asthma. Park Ridge, Ill, American College of Chest Physicians' 1975, pp 415–432
  • Santa Cruz R, Landa J, Hirsch J, et al: Tracheal mucus velocity in normal man and patients with obstructive lung disease: Effects of terbutaline. Am Rev Respir Dis 109: 458–463, 1974
  • Aviavdo DM: Toxicity of aerosols. J Clin Pharmacol 15: 86–104, 1975
  • Keighley JF: Response to sympathomimetic aerosols of differing particle size in subjects with chronic bronchitis. Am Rev Respir Dis 98: 879–882, 1968
  • Mercer TT: Production and characterization of aerosols. Arch Intern Med 131: 39–50, 1973
  • Hodgkin JE, Balchum OJ, Kass I, et al: Chronic obstructive airways diseases: Current concepts in diagnosis and comprehensive care. JAMA 232: 1243–1260, 1975
  • Goldberg I, Cherniack RM: The effect of nebulized bronchodilator delivered with and without I PPB on ventilatory function in chronic obstructive emphysema. Am Rev Respir Dis 91: 13–20, 1965
  • Chester EH, Racz I, Barlow PB, et al: Bronchodilator therapy: Comparison of acute response to three methods of administration. Chest 62: 394–399, 1972
  • Smelzer TH, Barnett TB: Bronchodilator aerosol: Comparison of administration methods. JAMA 223: 884–889, 1973
  • Amory DW, Burn ham SC, Cheney FW Jr: Comparison of the cardiopulmonary effects of subcutaneously administered epinephrine and terbutaline in patients with reversible airway obstruction. Chest 67: 279–286, 1975
  • Weinberger MM: Use of ephedrine in bronchodilator therapy. Pediatrdin North Am 22: 121–127, 1975
  • Weinberger MM, Bronsky EA: Evaluation of oral bronchodilator therapy in asthmatic children. J Pediatr 84: 421–429, 1974
  • Jenne JW: Rationale for methylxanthines in asthma. In Stein M (Editor),7 pp 391–413
  • Wilson AF, Novey HS, Qoninger P, et al: Cardiopulmonary effects of long-term bronchodilator administration. J Allergy Clin Immunol 58: 204–212, 1976
  • Svedmyr NL, Larsson SA, Thiringer GK: Development of “resistance” in beta-adrenergic receptors of asthmatic patients. Chest 69: 479–483, 1976
  • Plummer AL: The development of drug tolerance to beta-2 adrenergic agents. Chest (in press)
  • Sackner MA: Bronchodilator agents. Clin Notes Respir Dis 15: 3–14, 1976
  • Mitenko PA, Ogilvie RI: Rational intravenous doses of theophylline. N Engl J Med 289: 600–603, 1973
  • Jenne JW, Wyze MS, Rood FS, et al: Pharmacokinetics of theophylline: Application to adjustment of the clinical dose of aminophylline. Clin Pharmacol Ther 13: 349–360, 1972
  • Hendeles L, Bighley L, Richardson RH, et al: Frequent toxicity from intravenous aminophylline infusions in critically ill patients. Drug Intell Clin Pharmacol 11: 12–18, 1977
  • Koup JR, Schentag JJ, Vance JW, et al: System for clinical pharmacokinetic monitoring of theophylline therapy. Am J Hosp Pharm 33: 949–956, 1976
  • Stewart BN, Block AJ: A trial of aerosolized theophylline in relieving bronchospasm. Chest 69: 718–721, 1976
  • Weinberger M, Hendeles L: Pharmacotherapy of asthma. Am J Hosp Pharm 33: 1071–1080, 1976
  • Piafsky KM, Ogilvie RI: Dosage of theophylline in bronchial asthma. N Engl J Med 292: 1218–1222, 1975
  • McFadden ER Jr: Some observations on the pathophysiology of acute bronchial asthma. In Stein M (Editor),7 pp 339–349
  • Ridolfo AS, Kohlstaedt KG: A simplified method for the rectal installation of theophylline. Am J Med Sci 237: 585–589, 1959
  • Nadel JA: Neurophysiology aspects of asthma. In Austen KF, Lichtenstein LM (Editors),1 pp 29–37
  • Altounyan RE: Variation of drug action on airway obstruction in man. Thorax 19: 406–415, 1964
  • Poppius H, Salonnne Y: Comparative trial of a new anticholinergic bronchodilator, Sch 1000, and salbutamol in chronic bronchitis. Br Med J 4: 134–136, 1973
  • Simonsson BG, Jonson B, Ström B: Bronchodilatory and circulatory effects of inhaling increasing doses of an anticholinergic drug, ipratropium bromide (SCH 1000). Scand J Respir Dis 56: 138–149, 1975
  • Annis P, Landa J, Lichtiger M: Effect of atropine on velocity of tracheal mucus in anesthetized patients. Anesthesiology 44: 74–77, 1976

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.